{
    "nct_id": "NCT03164265",
    "official_title": "Safety and Preliminary Efficacy of Donor-derived Regulatory Dendritic Cell (DCreg) Infusion and Immunosuppression Withdrawal in Living Donor Liver Transplantation",
    "inclusion_criteria": "Donors\n\n1. Able to understand and provide informed consent;\n2. Male or female between the ages of 18-55;\n3. Meet all standard institutional and UNOS criteria for liver donation;\n4. For females of childbearing potential, a negative urine or serum pregnancy test;\n5. Negative for HIV (5th generation Test and NAT), HTLV-1, HTLV-2;(*)\n6. Negative for hepatitis C (antibody and NAT), hepatitis B (surface antigen and NAT)(*)\n\nRecipients\n\n1. Low risk recipient approved for LDLT, irrespective of gender, race, or ethnic background. Low risk is defined by absence of exclusion criteria (below).\n2. Between ages 18 and 65 years\n3. Undergoing de novo (first) liver transplant\n4. Female subjects of childbearing potential must have a negative pregnancy test upon study entry.\n5. Agreement to use contraception; according to the FDA Office of Women's Health (http://www.fda.gov/birthcontrol), there are a number of birth control methods that are more than 80% effective. Female participants of child-bearing potential must consult with their physician and determine the most suitable method(s) from this list to be used from the time that study treatment begins until 1 year after completion of immunosuppression withdrawal.\n\n(*)does not preclude donors from undergoing leukapheresis but cells may not be infused into recipient.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 55 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}